Insider Selling: Cypherpunk Technologies (NASDAQ:CYPH) Director Sells $34,400.00 in Stock

Cypherpunk Technologies (NASDAQ:CYPH) Director Thomas John Dietz sold 20,000 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $1.72, for a total value of $34,400.00. Following the completion of the sale, the director directly owned 132,500 shares of the company’s stock, valued at $227,900. The trade was a 13.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Cypherpunk Technologies Price Performance

CYPH opened at $1.71 on Friday. The company has a market capitalization of $184.28 million, a price-to-earnings ratio of 3.05 and a beta of 0.09. The firm’s fifty day moving average price is $0.81 and its two-hundred day moving average price is $0.82. Cypherpunk Technologies has a 1 year low of $0.27 and a 1 year high of $3.70.

Cypherpunk Technologies (NASDAQ:CYPH) last announced its earnings results on Wednesday, August 12th. The company reported $0.18 EPS for the quarter.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CYPH shares. Cantor Fitzgerald reissued an “overweight” rating and set a $1.60 target price on shares of Cypherpunk Technologies in a research report on Thursday. Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. Finally, Weiss Ratings upgraded Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 17th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Cypherpunk Technologies presently has a consensus rating of “Hold” and a consensus target price of $1.60.

Institutional Investors Weigh In On Cypherpunk Technologies

Large investors have recently modified their holdings of the stock. Acadian Asset Management LLC lifted its stake in Cypherpunk Technologies by 470.4% in the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock valued at $389,000 after purchasing an additional 1,056,047 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new stake in shares of Cypherpunk Technologies during the fourth quarter worth $56,000. HighTower Advisors LLC purchased a new stake in Cypherpunk Technologies during the 4th quarter worth about $59,000. Simplify Asset Management Inc. purchased a new stake in shares of Cypherpunk Technologies in the fourth quarter worth about $2,172,000. Finally, Texas Capital Bank Wealth Management Services Inc bought a new position in Cypherpunk Technologies in the 4th quarter valued at $121,000. Hedge funds and other institutional investors own 30.46% of the company’s stock.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.